Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations

多渠道沟通以改善服务不足人群的癌症教育和结果 (MICEO)

基本信息

  • 批准号:
    10892444
  • 负责人:
  • 金额:
    $ 20万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less likely to be vaccinated when compared to the general population and are more likely to develop second cancers caused by HPV as adults. St. Jude Comprehensive Cancer Center (SJCCC) is uniquely positioned to address observed disparities in HPV vaccination coverage among childhood cancer survivors by leveraging our unique reach across our catchment area and building on award-winning, state-of-the-art communication systems with those treated at SJCCC and their families. The overall goal of the proposed administrative supplement is to improve HPV vaccination coverage among childhood cancer survivors. The specific aims are to: (1) develop an innovative, culturally targeted, multi-channel educational campaign to enhance health literacy related to HPV vaccination and to improve HPV vaccination coverage among childhood cancer survivors; and (2) pilot test the multi-channel educational campaign to understand its impact on knowledge and intention and to inform the next steps. Our proposed plan will build on established and newly developed patient families and survivor-facing educational resources in English and Spanish, which are designed and disseminated to promote and facilitate health literacy. Our approach will be highly iterative and include engagement of key offices within St. Jude, including SJCCC Community Outreach and Engagement, HPV Cancer Prevention Program, Strategic Communication, Education and Outreach, Patient Family Centered Care, Patient Experience Office, Transition Oncology Program, After Completion of Therapy Clinic, and most importantly, through our regular interaction with patient families and childhood cancer survivors through the Patient Family Advisory Council and additional patient family advisors. The multi-channel campaign will focus on web-based resources and communities, social media platforms, Our St. Jude mobile application (app), traditional print formats, electronic medical record prompts for prescribed patient education, and peer-to-peer, patient family champion experiences. We will target the 10-30-year-old age group with approaches differentiated by 10-17-year-olds for whom parent/caregivers make vaccination decisions and 18-30-year olds who can make vaccination decisions for themselves, in most instances. We will develop and pilot test an HPV vaccination campaign across these multiple channels. Our project activities will be documented and monitored through a comprehensive process evaluation. The preliminary impact of our efforts will also be measured using qualitative, quantitative, and analytical data, including assessment of aggregated HPV vaccination rates before and after the campaign implementation period. Our efforts will be aligned with St. Jude communication and educational resources from the beginning to optimize sustainability. We will openly share our findings with other cancer centers and organizations serving childhood cancer survivors and continue to refine and test our approaches to ensure we are achieving impact through increased HPV vaccination coverage among childhood cancer survivors.
项目摘要 儿童癌症幸存者是HPV疫苗接种的高度优先、服务不足的人群。他们没有那么多 与普通人群相比,更有可能接种疫苗,更有可能发展为第二 成年后由人乳头瘤病毒引起的癌症。圣犹大综合癌症中心(SJCCC)的独特定位是 解决观察到的儿童癌症幸存者HPV疫苗接种覆盖率的差异 我们在我们的集水区独一无二的覆盖范围,并以屡获殊荣的最先进的通信为基础 与在SJCCC接受治疗的患者及其家人进行的系统检查。拟议的行政部门的总体目标 补充是为了提高儿童癌症幸存者的HPV疫苗接种覆盖率。具体目标是 (1)开展创新的、有文化针对性的、多渠道的教育活动,以增进健康 普及与HPV疫苗接种有关的知识,提高儿童癌症HPV疫苗接种覆盖率 幸存者;以及(2)试点测试多渠道教育活动,以了解其对知识和 目的并告知下一步行动。我们建议的计划将建立在现有和新开发的患者的基础上 家庭和面向幸存者的英语和西班牙语教育资源,这些资源是设计和 进行宣传,以促进和促进健康知识普及。我们的方法将是高度迭代的,包括 圣犹大内主要办公室的参与,包括圣公会社区推广和参与、人类免疫缺陷病毒 癌症预防计划,战略沟通,教育和外展,以患者家庭为中心 护理、患者体验办公室、过渡肿瘤学计划、完成治疗诊所后,以及MOST 重要的是,通过我们与患者家属和儿童癌症幸存者的定期互动, 患者家庭咨询委员会和额外的患者家庭顾问。多渠道宣传活动将重点放在 在基于网络的资源和社区、社交媒体平台上,我们的圣裘德移动应用程序(APP)、 传统的打印格式,电子病历提示,用于规定的患者教育,以及点对点, 耐心的家庭冠军体验。我们将以10-30岁的年龄组为目标,通过 由父母/照顾者为其做出疫苗接种决定的10-17岁儿童和18-30岁儿童区分开来 在大多数情况下,他们可以为自己做出疫苗接种决定。我们将开发和试行HPV 通过这多个渠道开展疫苗接种活动。我们的项目活动将被记录和监控 通过全面的流程评估。我们努力的初步影响也将用 定性、定量和分析数据,包括之前对HPV疫苗接种率的评估 并在运动实施期之后。我们的努力将与圣犹大的沟通和 从教育资源入手,优化可持续性。我们将公开分享我们的发现 其他癌症中心和组织为儿童癌症幸存者提供服务,并继续完善和测试我们的 确保我们通过增加儿童HPV疫苗接种覆盖率来实现影响的方法 癌症幸存者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES ROBERTS其他文献

CHARLES ROBERTS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES ROBERTS', 18)}}的其他基金

Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
  • 批准号:
    10660680
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
Development and Piloting of a Stigma Assessment Tool for Global Pediatric Cancer
全球儿童癌症耻辱评估工具的开发和试点
  • 批准号:
    10844719
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
Enhancing Precision of Pediatric Cancer Molecular Targets by Aggregating CCDI Genomic Data to Pediatric Cancer Knowledgebase
将CCDI基因组数据汇总到小儿癌症知识库,提高小儿癌症分子靶点的精准度
  • 批准号:
    10877602
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
Role of the SWI/SNF complex in tumor suppression
SWI/SNF 复合物在肿瘤抑制中的作用
  • 批准号:
    10463748
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Role of the SWI/SNF complex in tumor suppression
SWI/SNF 复合物在肿瘤抑制中的作用
  • 批准号:
    10248410
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Analysis of the role of the SWI/SNF complex in tumor suppression
SWI/SNF复合物抑制肿瘤的作用分析
  • 批准号:
    8689980
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Analysis of the role of the SWI/SNF complex in tumor suppression
SWI/SNF复合物抑制肿瘤的作用分析
  • 批准号:
    8579030
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
  • 批准号:
    7086815
  • 财政年份:
    2005
  • 资助金额:
    $ 20万
  • 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
  • 批准号:
    8676680
  • 财政年份:
    2005
  • 资助金额:
    $ 20万
  • 项目类别:
The function of Snf5, an epigenetic tumor suppressor
表观遗传肿瘤抑制因子 Snf5 的功能
  • 批准号:
    6906661
  • 财政年份:
    2005
  • 资助金额:
    $ 20万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了